Corrigendum: Metabolic-imaging of human glioblastoma live tumors: a new precision-medicine approach to predict tumor treatment response early [0.03%]
人胶质母细胞瘤代谢影像引导的精准医疗新方法：早期预测肿瘤治疗反应误差修正版论文
Mariangela Morelli,Francesca Lessi,Serena Barachini et al.
Mariangela Morelli et al.
[This corrects the article DOI: 10.3389/fonc.2022.969812.]. Keywords: FLIM (fluorescence lifetime imaging mi...
Published Erratum
Frontiers in oncology. 2025 Apr 24:15:1588290. DOI:10.3389/fonc.2025.1588290 2025
The impact of Inter-observation variation on radiomic features of pulmonary nodules [0.03%]
观察者间差异对肺结节影像组学特征的影响分析
Wenchao Zhu,Fangyi Xu,Kaihua Lou et al.
Wenchao Zhu et al.
Objective: In this study, we aimed to comprehensively and systematically analyze the radiomic features of pulmonary nodules and explore the influence of inter-observation variation (IOV) in segmentation regions of interes...
PITX1 as a grading, prognostic and tumor-infiltrating immune cells marker for chondrosarcoma: a public database-based immunoassay and tissue sample analysis [0.03%]
基于公共数据库的免疫测定和组织样本分析显示PITX1是软骨肉瘤的分级、预后和肿瘤浸润性免疫细胞标志物
Zikun Huang,Dongchen Liu,Ying Zhang et al.
Zikun Huang et al.
Background: Chondrosarcoma (CHS) is a rare bone cancer originating from chondrocytes, with high-grade cases associated with high mortality rates. However, the prognostic factors and therapeutic targets for CHS have not be...
Expression of SMURF family in pancreatic cancer and its effect on cell proliferation and migration [0.03%]
SMAD 特异性 E3 泛素蛋白连接酶 SMURF 家族在胰腺癌中的表达及其对细胞增殖和迁移的影响
Chen Zhang,Caoyi Li,Long Wu et al.
Chen Zhang et al.
Objective: This study aims to evaluate the expression of Smad ubiquitination regulatory factors (SMURFs) in pancreatic cancer and analyze their relationship with cancer staging and prognosis, and to investigate the potent...
Impact of primary cancer history and molecular landscape in therapy-related myeloid neoplasms [0.03%]
既往原发癌史和治疗相关骨髓肿瘤的分子特征对其影响
Alessandro Costa,Federica Pilo,Martina Pettinau et al.
Alessandro Costa et al.
Background: Therapy-related myeloid neoplasms (t-MN) are aggressive hematologic malignancies with poor prognosis and high-risk clinical features. Recent advances have highlighted the role of molecular data in refining pro...
Case Report: Two cases of chemotherapy refractory aggressive variant prostate cancer with extreme durable response to PARP inhibitor [0.03%]
个例报道：2例化疗难治性前列腺癌伴极端持久的PARP抑制剂反应
Bohao Jiang,Yifan Bi,Yiming Chen et al.
Bohao Jiang et al.
Background: Aggressive variant prostate cancer (AVPC) represents a distinct clinical subset characterized by resistance to novel hormone therapies and an unfavorable prognosis, frequently associated with the concurrent lo...
Case Report: Severe brigatinib-induced pneumonitis in a patient with EML4-ALK+ metastatic non-small cell lung adenocarcinoma [0.03%]
个例报告：EML4-ALK阳性转移性肺腺癌患者的严重brigatinib诱导肺炎病症报告
Khyati Somayaji Dasika,Megan Melody,Jyoti D Patel
Khyati Somayaji Dasika
Anaplastic lymphoma kinase (ALK) tyrosine kinase inhibitors (TKIs), such as brigatinib, are targeted therapies for metastatic non-small cell lung cancer (mNSCLC). We present a patient with echinoderm microtubule-associated protein-like 4 (E...
Exploring public preferences and demand for ovarian cancer screening: a discrete choice experiment [0.03%]
探索公众对卵巢癌筛查偏爱及需求的实证研究：基于离散选择实验的方法
Rebekah Hall,Anne E Spencer,Abigail Lloyd et al.
Rebekah Hall et al.
Introduction: Routine population-level screening may in the future reduce the high mortality rates associated with late-stage ovarian cancer diagnosis. However, the voluntary nature of screening means that understanding t...
Deep learning in assisting dermatologists in classifying basal cell carcinoma from seborrheic keratosis [0.03%]
深度学习在辅助皮肤科医生区分基底细胞癌和脂溢性角化病中的应用
Li-Hong Mei,Meng-Ke Cao,Jing Li et al.
Li-Hong Mei et al.
Objectives: This study aimed to evaluate the effectiveness of deep learning model in assisting dermatologists in classifying basal cell carcinoma (BCC) from seborrheic keratosis (SK). The goal was to assess whether AI-ass...
Prognostic role of inflammatory and tumor biomarkers in hilar cholangiocarcinoma patients receiving postoperative adjuvant therapy [0.03%]
肿瘤标志物和炎症标志物与肝门胆管癌术后辅助治疗预后之间的关系研究
Di Zeng,Saud Ahmad Saad,Zhen You et al.
Di Zeng et al.
Background: Hilar cholangiocarcinoma (HCCA) is an aggressive cancer with poor prognosis after surgery. The systemic immune-inflammation index (SII) has been proposed as a prognostic marker, but its relationship with other...